Evidence map›Paper›PMID 31511782›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2019

Effects of Xuesaitong on the Pharmacokinetics of Losartan: An

Weina Ma, Lei Lv, Jungang Guo, Yongjun Meng, Yinghua Wang, Xiaoliang Yang, Lijun Zhu, Hua Nian, Liang Zhao

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Weina MaDepartment of Pharmacy, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai, China.ORCID https://orcid.org/0000-0001-9565-8494
Lei LvShanghai Eastern Hepatobiliary Surgery Hospital, Shanghai, China.ORCID https://orcid.org/0000-0001-5850-3397
Jungang GuoDepartment of Thoracic Surgery, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai, China.
Yongjun MengDepartment of Pharmacy, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai, China.
Yinghua WangDepartment of Pharmacy, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai, China.
Xiaoliang YangShanghai Eastern Hepatobiliary Surgery Hospital, Shanghai, China.
Lijun ZhuShanghai Eastern Hepatobiliary Surgery Hospital, Shanghai, China.
Hua NianDepartment of Pharmacy, Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine, Shanghai University of T.C.M., Shanghai, China.ORCID https://orcid.org/0000-0002-6581-5820
Liang ZhaoDepartment of Pharmacy, Shanghai Baoshan Luodian Hospital, Shanghai, China.ORCID https://orcid.org/0000-0002-3375-1156
Jiading District Central Hospital · CNSecond Military Medical University · CNShanghai University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to examine whether Xuesaitong, a multiherbal formulation for coronary heart disease, alters the pharmacokinetics of losartan. Adult male Sprague Dawley rats randomly received losartan (10 mg/kg) or losartan plus Xuesaitong (10 mg/kg) through an oral gavage (

Identifiers

PMID31511782
PMCPMC6710810
OpenAlexW2967394510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.